ArticleDiscover oncology2025

Pan-cancer analysis and single-cell analysis identifies the CENPN as a biomarker for survival prognosis and immunotherapy.

Nie Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.